Tigecycline | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Tigecycline
HEALTH CANADA PATENTS

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Tigecycline

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

24 API Suppliers, 12 USDMF, 3 CEP/COS, 6 EU WC, 8 NDC API, 17 Listed Suppliers, $ API Reference Price

24 API Suppliers
12 USDMF
3 CEP/COS
6 EU WC
8 NDC API
17 Listed Suppliers
$ API Reference Price

FINISHED DOSAGE FORMULATIONS

42 FDF Dossiers, 9 FDA Orange Book, 5 Europe, 2 Canada, 7 South Africa, 19 Listed Dossiers

42 FDF Dossiers
9 FDA Orange Book
5 Europe
2 Canada
7 South Africa
19 Listed Dossiers

RELATED EXCIPIENT COMPANIES

2 Faran Shimi Pharmaceutical, 3 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Actylis, 2 DFE Pharma, 14 Kerry, 2 Microlex e.U, 2 Pluviaendo, 2 Sigachi Industries

2 Faran Shimi Pharmaceutical
3 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
1 Pfanstiehl
1 Actylis
2 DFE Pharma
14 Kerry
2 Microlex e.U
2 Pluviaendo
2 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

20 Fillers, Diluents & Binders, 7 Direct Compression, 4 Granulation, 4 Co-Processed Excipients, 3 Parenteral, 1 Thickeners and Stabilizers

20 Fillers, Diluents & Binders
7 Direct Compression
4 Granulation
4 Co-Processed Excipients
3 Parenteral
1 Thickeners and Stabilizers

DIGITAL CONTENT

8 NEWS #PharmaBuzz

8 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 3 Finished Drug Prices, 7 Annual Reports

2 US Medicaid Prescriptions
3 Finished Drug Prices
7 Annual Reports

MARKET PLACE

16 APIs, 9 FDF Dossiers

16 APIs
9 FDF Dossiers

PATENTS & EXCLUSIVITIES

7 US Patents, 2 Health Canada Patents

7 US Patents
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 2 Others

1 USP
2 Others

$ API Ref.Price (USD/KG) : 32,716 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 1Pfizer Canada Inc.

02 1Pfizer Canada ULC

filter Patent Reset all filters

2 All

01 12079692

02 12602089

filter Product Reset all filters

2 All

01 2Tigecycline

filter Dosage Reset all filters

2 All

01 2Powder for Solution

filter Exp Date Reset all filters

2 All

01 12012-10-02

02 12026-03-13

Product Main Page

01

Pfizer Canada Inc.

Tigecycline

Pharma, Lab & Chemical Expo

Not Confirmed

Pfizer Canada Inc.

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-10-02

Date Granted : 2004-06-08

Tigecycline

Brand Name : TYGACIL

Patent Number : 2079692

Filing Date : 1992-10-02

Strength per Unit : 50 mg / vial

Dosage Form : Powder for Solution

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2012-10-02

Date Granted : 2004-06-08

Portfolio PDF

Product Web Link

Digital Content

02

Pfizer Canada ULC

Tigecycline

Pharma, Lab & Chemical Expo

Not Confirmed

Pfizer Canada ULC

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-03-13

Date Granted : 2013-04-30

Tigecycline

Brand Name : TYGACIL

Patent Number : 2602089

Filing Date : 2006-03-13

Strength per Unit : 50 mg / vial

Dosage Form : Powder for Solution

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2026-03-13

Date Granted : 2013-04-30

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?